Table 1.
All Overweight Completers N=317 |
BWL + Goal N= 52 |
Goal No BWL N=227 |
No Goal N=38 |
P value Between Groups | |
---|---|---|---|---|---|
Age, yr | 65.9 ± 10.5 | 67.1 ± 8.8 | 65.1 ± 10.8 | 68.6 ± 10.4 | .11 |
Male Sex, % | 74 | 73 | 75 | 74 | .96 |
aWeight, kg | 94.0 ± 16.6 | 99.9 ± 19.6 | 94.0 ± 15.6 | 85.5 ± 14.3 | .002 |
BMI, kg/m2 | 31.9 ± 5.0 | 33.4 ± 4.8 | 32.1 ± 5.0 | 29.0 ± 3.7 | .001 |
Body Weight, lb | 208.4 ± 38.3 | 225.9 ± 46.6 | 207.5 ± 35.4 | 189.1 ± 31.0 | .0001 |
WC, inches, | 43.1 ± 4.4 | 44.5 ± 5.1 | 43.1 ± 4.2 | 40.9 ± 4.0 | .0008 |
Short-term WL Goal, kg | 9.2 ± 6.8 | 13.9 ± 6.0 | 9.7 ± 6.0 | n/a | .0001 |
Long-term WL Goal, kg | 19.4 ± 16.9 | 29.2 ± 20.6 | 20.3 ± 14.7 | 1.3 ± 2.6 | .0001 |
HbA1c, % | 6.2 ± 1.3 | 6.0 ± 0.9 | 6.2 ± 1.3 | 6.3 ± 1.3 | .5 |
aVO2peak, mLO2*kg−1*min−1 | 18.5 ± 5.6 | 18.7 ± 4.3 | 18.7 ± 5.9 | 17.5 ± 4.7 | .53 |
aHandgrip, kg | 35.9 ± 11.1 | 35.7 ± 11.5 | 36.6 ± 11.1 | 32.2 ± 9.7 | .12 |
Interval Training, % | 39.7 | 57.7 | 38.8 | 28.9 | .02 |
Education, yr | 14.6 ± 2.7 | 15.1 ± 2.6 | 14.6 ± 2.6 | 14.1 ± 2.9 | .25 |
Metabolic Syndrome | 66.9% | 71.1% | 66.5% | 71.1% | .71 |
Cardiac Diagnosis (Surgery vs No Surgery) | 105/212 | 15/37 | 75/152 | 15/23 | .57 |
T2DM, Yes/No | 87/230 | 10/42 | 64/163 | 13/25 | .26 |
CoMorbid Score | 0.9 ± 1.3 | 1.1 ± 1.5 | 0.9 ± 1.3 | 1.0 ± 1.4 | .32 |
MOS SF-36 | 61.9 ± 25.8 | 63.3 ± 27.5 | 63.4 ± 25.3 | 56.4 ± 24.1 | .06 |
PHQ-9 | 4.1 ± 4.1 | 3.1 ± 3.6 | 4.2 ± 4.2 | 5.1 ± 3.7 | .07 |
CR sessions, n | 30.7 ± 8.7 | 34.1 ± 5.0 | 29.7 ± 7.4 | 31.8 ± 6.8 | .003 |
Medications, Yes/No | |||||
Insulin | 35/282 | 6/46 | 25/202 | 4/34 | .99 |
Metformin | 40/277 | 8/44 | 31/196 | 1/37 | .13 |
Sulfonyurea | 11/306 | 3/49 | 8/219 | 0/38 | .33 |
SGLT2 | 7/310 | 1/51 | 6/221 | 0/38 | .59 |
GLP-1 | 4/313 | 1/51 | 2/225 | 1/37 | .13 |
DPP-4 | 10/307 | 2/50 | 7/220 | 1/37 | .94 |
BetaBlockers | 273/44 | 45/7 | 191/36 | 37/1 | .71 |
First cardiac rehabilitation session
Data expressed as mean ± SD unless otherwise indicated
Abbreviations: BMI, body mass index; CR, cardiac rehabilitation; MOS SF-36, Medical Outcomes Study Short Form-36; PHQ-9, Patient Health Questionnaire-9; T2DM, type 2 diabetes mellitus; WC, waist circumference; WL weight loss